Unjoni Ewropea - Malti - EMA (European Medicines Agency)

renable pharma limited - enclomifene citrate - ipogonadiżmu - - ormoni tas-sess u modulaturi ta ' l-ġenitali-sistema, - it-trattament tal-hypogonadotropic ipogonadotrofiku fl-irġiel.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

xbiotech germany gmbh - antikorp monoklonali uman igg1 speċifiku għal interleukin-1 alfa tal-bniedem - neoplażmi kolorettali - aġenti antineoplastiċi - it-trattament tal-kanċer metastatiku tal-kolorektum.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

ab science - masitinib - neoplażmi pankreatiċi - inibituri tal-proteina kinase - it-trattament ta mhux resectable lokalment avvanzata jew metastatika tal-kanċer tal-frixa.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

novartis europharm ltd - serelaxin - insuffiċjenza tal-qalb - - vażodilataturi l-oħra użata fil-mard tal-qalb - it-trattament ta ' insuffiċjenza tal-qalb.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

teva pharma gmbh - laquinimod - sklerosi multipla - il-kura tal-isklerożi multipla.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

laboratoires smb s.a.   - budesonide, salmeterol - ażma - treatment of asthma.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

wyeth europa ltd - gemtuzumab ozogamicin - lewkimja, mijelojda, akuta - aġenti antineoplastiċi - mill-ġdid tal-kura ta 'induzzjoni ta cd33-pożittivi aml f'pazjenti adulti fl-ewwel rikaduta li mhumiex kandidati għall-oħra intensiv mill-ġdid l-induzzjoni ta' kimoterapija (e. doża għolja ara-c) u tissodisfax mill-inqas wieħed mill-kriterji li ġejjin: t-tul ta'l-ewwel remissjoni 60 sena.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

neutec pharma plc - rikombinanti uman monoklonali ta ' antikorp li hsp - kandidjasi - antimikotiċi għal użu sistemiku - trattament ta 'kandidjasi invażiva f'pazjenti adulti, f'kombinazzjoni ma' amphotericin b jew tal-lipidi-formulazzjoni ta ' amphotericin b.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

d&a pharma - sodium oxybate - substance withdrawal syndrome; alcohol abstinence - drogi oħra tas-sistema nervuża - substitution treatment for alcohol dependence within a framework of careful medical supervision along with continuous psychosocial support and social rehabilitation. treatment should be initiated only in patients resistant to existing interventions or in patients for whom existing therapies are contra-indicated or not recommended.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - pexidartinib - giant cell tumor of tendon sheath; synovitis, pigmented villonodular - aġenti antineoplastiċi - treatment of tenosynovial giant cell tumour.